Evidence map›Paper›PMID 41122179›Full record

ArticleFrontiers in immunology2025

IL-7 promotes the formation of DNA double strand breaks and DNA repair in murine pro-B cells.

Alessia Lamolinara, Chiara Di Lisio, Julie A Hixon, Pasquale Simeone, Antonella De Cola, Maria D Falco, Thomas J Meyer, Alessio Ferrone, Domenico Genovesi, Paola Lanuti and 5 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alessia LamolinaraDepartment of Neurosciences, Imaging and Clinical Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Chiara Di LisioDepartment of Medicine and Aging Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Julie A HixonCytokines and Immunity Section, Cancer Innovation Laboratory (CIL), National Institutes of Health (NIH), National Cancer Institute Frederick, Frederick, MD, United States.
Pasquale SimeoneCenter for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Antonella De ColaDepartment of Oncology, Early Cancer Institute, University of Cambridge, Cambridge, United Kingdom.
Maria D FalcoDepartment of Radiation Oncology, "G. d'Annunzio" University of Chieti-Pescara, "S.S. Annunziata" Hospital, Chieti, Italy.
Thomas J MeyerCCR Collaborative Bioinformatics Resource (CCBR), National Institutes of Health (NIH), National Cancer Institute Frederick, Frederick, MD, United States.
Alessio FerroneDepartment of Medicine and Aging Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Domenico GenovesiDepartment of Radiation Oncology, "G. d'Annunzio" University of Chieti-Pescara, "S.S. Annunziata" Hospital, Chieti, Italy.
Paola LanutiCenter for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Wenqing LiCytokines and Immunity Section, Cancer Innovation Laboratory (CIL), National Institutes of Health (NIH), National Cancer Institute Frederick, Frederick, MD, United States.
Vincenzo De LaurenziCenter for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Manuela IezziDepartment of Neurosciences, Imaging and Clinical Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Francesca B AielloCenter for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Scott K DurumCytokines and Immunity Section, Cancer Innovation Laboratory (CIL), National Institutes of Health (NIH), National Cancer Institute Frederick, Frederick, MD, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In pro-B cells, VDJ recombination at the immunoglobulin heavy chain locus is impaired. B cell progenitor recombination implies the formation of DNA double strand breaks (DSBs) by the RAG recombinase, which are subsequently repaired by specific mechanisms. We cultured primary murine pro-B cells with IL-7 to evaluate H2AX histone phosphorylation, a well-established marker of DSB formation (γ-H2AX foci) and the expression of proteins involved in DNA repair. Our results indicated that IL-7 upregulated the expression of several molecules involved in homologous recombination, the most accurate DSB repair mechanism. Quantitative analyses of γ-H2AX foci revealed that IL-7 significantly increased DSB formation in a time-dependent manner. Furthermore, γ-H2AX expression was altered in RAG2-deficient pro-B cells and absent in RAG1-deficient pro-B cells treated with IL-7, demonstrating the requirement of both RAG1 and RAG2 recombinase subunits. CD43 expression inversely correlates with the degree of cell differentiation and its level is often evaluated to assess the B lymphoid developmental stage. We observed that IL-7 upregulated CD43 expression and the percentage of large CD43/γ-H2AX double-positive cells, suggesting an effect on less differentiated, immature cells. Notably, we also found that IL-7 increased radiation-induced DSBs, while simultaneously supporting cell survival. This study uncovers novel effects of IL-7 on B cell differentiation, DSB formation, and DNA repair. It is well established that IL-7 promotes the proliferation and survival of acute lymphoblastic leukemia (ALL) cells. Our data suggest that drugs targeting IL-7 could improve ALL therapeutic protocols.

Indexed as

DNA Breaks, Double-StrandedDNA RepairInterleukin-7Precursor Cells, B-LymphoidAnimalsCell DifferentiationCells, CulturedDNA-Binding ProteinsHistonesHomeodomain ProteinsMiceMice, Inbred C57BLMice, KnockoutDNA-Binding Proteinsgamma-H2AX protein, mouseHistonesHomeodomain ProteinsInterleukin-7interleukin-7, mouseRAG-1 proteinRag2 protein, mousecell survivalDNA repairdouble strand breaksIL-7pro-B cells

Identifiers

PMID41122179
PMCPMC12535990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.